The Impact of Obesity vs Non-Obesity Body Mass Index (BMI) on Adalimumab Efficacy in Ulcerative Colitis

Author Information

Mekhala Santebennur, Drexel UniversityFollow
Kathryn Mozzochi, Drexel UniversityFollow
Diana Gavilanes MD, UPMC Central PaFollow
Evelyn J. Calderon Martinez MD, UPMC Central PaFollow
Anas Atrash MD, UPMC Central PaFollow

Keywords:

IBD, Ulcerative Colitis, BMI, Biologics, Adalimumab

Recommended Citation

Santebennur, Mekhala; Mozzochi, Kathryn; Gavilanes, Diana MD; Calderon Martinez, Evelyn J. MD; and Atrash, Anas MD, "The Impact of Obesity vs Non-Obesity Body Mass Index (BMI) on Adalimumab Efficacy in Ulcerative Colitis" (2025). Tower Health Research Day. 18.
https://scholarcommons.towerhealth.org/th_researchday/2024-2025/in_person_posters/18

Institutional Review Board/Institutional Animal Care and Use Committee Approved or Exempt

Not Applicable